Clinical Trial Update: Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™ [Phase 3]

View source ↗

Summary

Phase 3 trial in children evaluating primary vaccination with a pneumococcal conjugate vaccine (GSK 1024850A or Prevenar) alongside Hib vaccine Hiberix; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Infections
• Pneumococcal Infections

Drugs mentioned

• GSK 1024850A
• Hiberix (Haemophilus influenzae type b conjugate vaccine)
• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2010-06-14